• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Israel·Healthcare·ALMD.TA
Share

Allmed Solutions Ltd Stocks

ILA 31.8Last Updated 30.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

ILA 97485.30583

ILA 31.8
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Based in Caesarea, Israel, Allium Medical Solutions Ltd. specializes in the creation, manufacturing, and global distribution of advanced, long-term medical stents. These innovative devices are fully covered, designed for expansion, and are retrievable, serving to alleviate various obstructions within the urinary and gastrointestinal (GI) tracts. Their product portfolio encompasses a range of specialized stents, including those for ureteric, bulbar, triangular and round prostatic, and biliary applications.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.11.2026 16:18

Morning in New York: The High-Tech Sector Cools Off Ahead of the Election

02.11.2026 16:04

"I know he's an idiot": Ryanair CEO assesses the business benefits of his feud with Musk

02.11.2026 15:50

A "Cleaning-Out" Pullback: Morgan Stanley Suggests Entering the Market Ahead of a Rally to 8,000 Points

02.11.2026 15:10

"Some People Might Get Nervous": What Lies Ahead for the Tenge and Investors in Kazakh Bonds

02.11.2026 13:46

Goldman Sachs has raised its oil price forecast for 2027. What risks does the bank see?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026